455900
ANGEL ROBOTICS Co., Ltd. engages in the research, development, manufacturing and selling of intelligent wearable robots. It offers ANGEL LEGS M20 for incomplete paralysis patients; MW10 for muscular reconstruction, and joints athletic recovery; ANGEL SUIT H10, a walking preparation robot; gear's; and kits. ANGEL ROBOTICS Co., Ltd. was formerly known as SG Robotics Co., Ltd. and changed its name t… Read more
455900 (455900) - Total Liabilities
Latest total liabilities as of March 2025: ₩5.02 Billion KRW
Based on the latest financial reports, 455900 (455900) has total liabilities worth ₩5.02 Billion KRW as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
455900 - Total Liabilities Trend (2021–2023)
This chart illustrates how 455900's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
455900 Competitors by Total Liabilities
The table below lists competitors of 455900 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Methode Electronics Inc
NYSE:MEI
|
USA | $608.10 Million |
|
Wayz Intelligent Manufacturing Technology Co. Ltd. A
SHG:688211
|
China | CN¥2.96 Billion |
|
Dropsuite Ltd
AU:DSE
|
Australia | AU$6.46 Million |
|
Beijing Tianma Intelligent Control Technology Co. Ltd. A
SHG:688570
|
China | CN¥1.41 Billion |
|
Alfen Beheer BV
AS:ALFEN
|
Netherlands | €159.77 Million |
|
Icelandair Group hf
IC:ICEAIR
|
Iceland | Ikr1.77 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$284.53 Million |
Liability Composition Analysis (2021–2023)
This chart breaks down 455900's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 18.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.24 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how 455900's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for 455900 (2021–2023)
The table below shows the annual total liabilities of 455900 from 2021 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | ₩12.64 Billion | -65.12% |
| 2022-12-31 | ₩36.24 Billion | +0.49% |
| 2021-12-31 | ₩36.07 Billion | -- |